Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

Release Date:

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

Title
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
Copyright
Release Date

flashback